KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Shares Outstanding (Diluted Average) (2016 - 2025)

Sarepta Therapeutics has reported Shares Outstanding (Diluted Average) over the past 8 years, most recently at $100.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $100.1 million for Q4 2025, down 7.19% from a year ago — trailing twelve months through Dec 2025 was $100.1 million (down 7.19% YoY), and the annual figure for FY2025 was $100.1 million, down 7.19%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $100.1 million at Sarepta Therapeutics, up from $98.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for SRPT hit a ceiling of $107.9 million in Q4 2024 and a floor of $88.6 million in Q3 2023.
  • Median Shares Outstanding (Diluted Average) over the past 3 years was $99.1 million (2024), compared with a mean of $98.0 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 16.75% in 2024 and later dropped 7.19% in 2025.
  • Sarepta Therapeutics' Shares Outstanding (Diluted Average) stood at $92.4 million in 2023, then grew by 16.75% to $107.9 million in 2024, then fell by 7.19% to $100.1 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $100.1 million (Q4 2025), $98.5 million (Q3 2025), and $106.6 million (Q2 2025) per Business Quant data.